Verisign Business Model 2026: The Internet’s Tollbooth Sponsored by Lake Region State CollegeTrain for the jobs AI can’t take—yet. Most investors have heard of Verisign, but very few understand what the company actually does. And that’s partly because Verisign isn’t a typical tech firm — it’s a toll-collector on the global internet. It doesn’t run […]
Verisign Business Model 2026: The Internet’s Tollbooth Read More »
Roblox Business Model 2026: How the Platform Makes Money Sponsored by Lake Region State CollegeTrain for the jobs AI can’t take—yet. Roblox isn’t a traditional gaming company. It’s a full-scale digital economy powered by user-generated worlds, virtual currency, and platform-level monetization. Millions of players interact inside experiences built by creators, and Roblox captures value from
Roblox Business Model 2026: How the Platform Makes Money Read More »
Molina Healthcare 2026 Forecast: Costs Surge, Profits Crash Sponsored by Lake Region State CollegeTrain for the jobs AI can’t take—yet. Molina Healthcare’s latest results confirm what analysts feared all quarter: the Medicaid-focused insurer is entering one of the most difficult operating environments in a decade. A rare quarterly loss, collapsing guidance, and industry-wide cost inflation
Molina Healthcare 2026 Forecast: Costs Surge, Profits Crash Read More »
AI Tax Prep 2026: TurboTax & H&R Block Stock Outlook AI tax prep 2026 is transforming the entire tax industry, forcing companies like TurboTax and H&R Block to rethink their business models and their 2026 stock outlook. With ChatGPT now handling tax guidance as well as dedicated tax software, the competitive landscape is being rewritten
AI Tax Prep 2026: TurboTax & H&R Block Stock Outlook Read More »
Texas Instruments to Acquire Silicon Labs in $7.5B Deal Texas Instruments has announced a major strategic move with its plan to acquire Silicon Labs in a $7.5 billion deal, reshaping its position in the semiconductor industry. Sponsored by Lake Region State College(Your future in business, finance, and tech begins at Lake Region.) Overview: What the
Texas Instruments to Acquire Silicon Labs in $7.5B Deal Read More »
Is Kinross Gold (KGC) a Buy in 2026? Overview: Kinross Gold in a Pivotal Macro Moment Kinross Gold Corp (NYSE: KGC) enters 2026 in one of the strongest gold-price environments in modern history. With global uncertainty rising, investor appetite for safe-haven assets intensifying, and interest rate expectations shifting, gold miners have quickly re-emerged as market
Is Kinross Gold (KGC) a Buy in 2026? Read More »
Walmart Becomes First Retailer to Reach $1 Trillion Value Sponsored by Lake Region State College(Your future in business, finance, and tech begins at Lake Region.) Overview: A Historic Milestone in Retail and Markets Walmart has officially become the first traditional retailer in history to reach a $1 trillion market valuation, a milestone previously reserved for
Walmart Becomes First Retailer to Reach $1 Trillion Value Read More »
Lukoil Deal: What Carlyle’s Bid Means for Balkan Fuel Markets Lukoil is suddenly at the center of one of the biggest energy shakeups in years, as Carlyle explores buying the sanctioned Russian oil giant’s Balkan assets — a deal that could redefine fuel security across Bulgaria, Romania, and Serbia. If you like your geopolitics with
Lukoil Deal: What Carlyle’s Bid Means for Balkan Fuel Markets Read More »
Michael Burry’s New GameStop Bet Explained: The 5 Real Takeaways If you’ve followed Michael Burry for longer than five minutes, you know this: he doesn’t make random trades. So when the man behind The Big Short suddenly discloses a new stake in GameStop, everyone instantly assumes 2021 is back from the dead. But Burry’s thesis
Michael Burry’s New GameStop Bet Explained: The 5 Real Takeaways Read More »
Merck Walks Away From Revolution Medicines — But the Buyout Battle Is Now More Interesting Merck’s decision to pause talks with Revolution Medicines has major implications for biotech deal-making in 2026. Why the talks cooled, what was really at stake, and why a bidding war could still erupt in oncology’s hottest niche. For weeks, biotech